» Articles » PMID: 26477653

Tracer Kinetic Modelling for DCE-MRI Quantification of Subtle Blood-brain Barrier Permeability

Overview
Journal Neuroimage
Specialty Radiology
Date 2015 Oct 20
PMID 26477653
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

There is evidence that subtle breakdown of the blood-brain barrier (BBB) is a pathophysiological component of several diseases, including cerebral small vessel disease and some dementias. Dynamic contrast-enhanced MRI (DCE-MRI) combined with tracer kinetic modelling is widely used for assessing permeability and perfusion in brain tumours and body tissues where contrast agents readily accumulate in the extracellular space. However, in diseases where leakage is subtle, the optimal approach for measuring BBB integrity is likely to differ since the magnitude and rate of enhancement caused by leakage are extremely low; several methods have been reported in the literature, yielding a wide range of parameters even in healthy subjects. We hypothesised that the Patlak model is a suitable approach for measuring low-level BBB permeability with low temporal resolution and high spatial resolution and brain coverage, and that normal levels of scanner instability would influence permeability measurements. DCE-MRI was performed in a cohort of mild stroke patients (n=201) with a range of cerebral small vessel disease severity. We fitted these data to a set of nested tracer kinetic models, ranking their performance according to the Akaike information criterion. To assess the influence of scanner drift, we scanned 15 healthy volunteers that underwent a "sham" DCE-MRI procedure without administration of contrast agent. Numerical simulations were performed to investigate model validity and the effect of scanner drift. The Patlak model was found to be most appropriate for fitting low-permeability data, and the simulations showed vp and K(Trans) estimates to be reasonably robust to the model assumptions. However, signal drift (measured at approximately 0.1% per minute and comparable to literature reports in other settings) led to systematic errors in calculated tracer kinetic parameters, particularly at low permeabilities. Our findings justify the growing use of the Patlak model in low-permeability states, which has the potential to provide valuable information regarding BBB integrity in a range of diseases. However, absolute values of the resulting tracer kinetic parameters should be interpreted with extreme caution, and the size and influence of signal drift should be measured where possible.

Citing Articles

Visual analysis of emerging topics and trends in contrast agent extravasation research in medical imaging: a bibliometric study using CiteSpace and VOSviewer.

Liu Y, Dong Y, Zhou W, Yu J Front Med (Lausanne). 2025; 12:1472637.

PMID: 40046933 PMC: 11879959. DOI: 10.3389/fmed.2025.1472637.


Tracer kinetic model detecting heterogeneous blood-brain barrier permeability to water and contrast agent in Alzheimer's disease and dementia with Lewy bodies.

Xu Z, Ji Y, Wen C, Gan J, Chen Z, Li R Alzheimers Dement. 2025; 21(2):e14529.

PMID: 39936244 PMC: 11815205. DOI: 10.1002/alz.14529.


Blood-brain barrier breakdown in brain ischemia: Insights from MRI perfusion imaging.

Sasannia S, Leigh R, Bastani P, Shin H, van Zijl P, Knutsson L Neurotherapeutics. 2024; 22(1):e00516.

PMID: 39709246 PMC: 11840350. DOI: 10.1016/j.neurot.2024.e00516.


Optimisation of Animal Handing and Timing of 2-deoxy-2-[F]fluoro-D-glucose PET Tumour Imaging in Mice.

Hesketh R, Lewis D, Brindle K Mol Imaging Biol. 2024; 26(6):965-976.

PMID: 39528890 PMC: 11634969. DOI: 10.1007/s11307-024-01956-4.


Measurement variability of blood-brain barrier permeability using dynamic contrast-enhanced magnetic resonance imaging.

Varatharaj A, Jacob C, Darekar A, Yuen B, Cramer S, Larsson H Imaging Neurosci (Camb). 2024; 2:1-16.

PMID: 39449749 PMC: 11497077. DOI: 10.1162/imag_a_00324.


References
1.
Sourbron S, Ingrisch M, Siefert A, Reiser M, Herrmann K . Quantification of cerebral blood flow, cerebral blood volume, and blood-brain-barrier leakage with DCE-MRI. Magn Reson Med. 2009; 62(1):205-17. DOI: 10.1002/mrm.22005. View

2.
Brickman A, Zahra A, Muraskin J, Steffener J, Holland C, Habeck C . Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging. Psychiatry Res. 2009; 172(2):117-20. PMC: 2763417. DOI: 10.1016/j.pscychresns.2008.11.006. View

3.
Larsson H, Courivaud F, Rostrup E, Hansen A . Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhanced T(1)-weighted MRI at 3 tesla. Magn Reson Med. 2009; 62(5):1270-81. DOI: 10.1002/mrm.22136. View

4.
Topakian R, Barrick T, Howe F, Markus H . Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J Neurol Neurosurg Psychiatry. 2009; 81(2):192-7. DOI: 10.1136/jnnp.2009.172072. View

5.
Valdes Hernandez M, Ferguson K, Chappell F, Wardlaw J . New multispectral MRI data fusion technique for white matter lesion segmentation: method and comparison with thresholding in FLAIR images. Eur Radiol. 2010; 20(7):1684-91. PMC: 2882045. DOI: 10.1007/s00330-010-1718-6. View